PP_1170x120_10-25-21

NIH director Dr. Francis  Collins

NIH launches clinical trails network to test COVID-19 vaccines, other tools

NIH launches clinical trails network to test COVID-19 vaccines, other tools

WASHINGTON — The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has established a new clinical trials network that aims to enroll thousands of volunteers in large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies intended to protect people from COVID-19. The COVID-19 Prevention Trials

NIH mobilizes national innovation initiative for COVD-19 diagnostics

NIH mobilizes national innovation initiative for COVD-19 diagnostics

BETHESDA, Md. — The National Institutes of Health (NIH) announced Wednesday a new initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies, a pivotal component needed to return to normal during this unprecedented global pandemic. With a $1.5 billion investment from federal stimulus funding, the newly launched Rapid Acceleration of Diagnostics (RADx)

NIH to launch public-private partnership to speed COVID-19 vaccine and treatment options

NIH to launch public-private partnership to speed COVID-19 vaccine and treatment options

ROCKVILLE, Md.— The National Institutes of Health and the Foundation for the NIH (FNIH) are bringing together more than a dozen leading biopharmaceutical companies, the Health and Human Services Office of the Assistant Secretary for Preparedness and Response, the Centers for Disease Control and Prevention, the U.S. Food and Drug Administration and the European Medicines